DERMATITIS, ATOPIC

This study tests a new medication called 611 in Chinese teenagers aged 12 to 17 with moderate-to-severe atopic dermatitis (eczema). The drug aims to reduce skin redness, itching, and rash by blocking a protein involved in inflammation. Participants will receive either 611 or a pl…

This study tests an experimental drug called JNJ-95597528 in adults with moderate to severe atopic dermatitis (eczema). About 180 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness, thickness, and itching. The main goal is to m…

This study tests a new injectable drug called amlitelimab for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with other biologic or JAK inhibitor treatments. Participants will continue using topical steroids and receive either aml…

This study looks at how well the oral medication abrocitinib works for people with moderate-to-severe eczema (atopic dermatitis) who have already tried up to two biologic drugs without success or had side effects. About 150 participants aged 12 and older will be followed in real-…

This study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how much their skin improves over 12 months in real-world settings, not a controlled lab. The goal is to see how well the drug…

This study is checking how safe and effective the drug Cibinqo (abrocitinib) is for people with moderate to severe atopic dermatitis, a type of eczema. About 1,100 participants in Korea will take the tablet by mouth and be followed for one year. Researchers will track side effect…

This study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…

This study looks at how treatments for eczema (atopic dermatitis) change the types and amounts of bacteria on the skin. Researchers will compare skin samples from people with eczema and healthy volunteers over one year. The goal is to understand how treatments affect the skin's m…